Aclaris Therapeutics
ACRS
ACRS
97 hedge funds and large institutions have $58.1M invested in Aclaris Therapeutics in 2024 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 20 increasing their positions, 38 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2.59% less ownership
Funds ownership: 76.75% → 74.15% (-2.6%)
14% less capital invested
Capital invested by funds: $67.8M → $58.1M (-$9.68M)
47% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 38
Holders
97
Holding in Top 10
1
Calls
$51K
Puts
$4K
Top Buyers
| 1 | +$3.95M | |
| 2 | +$2.12M | |
| 3 | +$2.08M | |
| 4 |
AC
Aldebaran Capital
Carmel,
Indiana
|
+$944K |
| 5 |
Goldman Sachs
New York
|
+$848K |
Top Sellers
| 1 | -$3.49M | |
| 2 | -$2.2M | |
| 3 | -$1.26M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$870K |
| 5 |
Renaissance Technologies
New York
|
-$826K |